A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Lung Cancer, Non-Small Cell
Interventions
BIOLOGICAL

Dostarlimab

Dostarlimab will be administered.

BIOLOGICAL

Belrestotug

Belrestotug will be administered.

BIOLOGICAL

Pembrolizumab

Pembrolizumab will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (134)

807

GSK Investigational Site, Kaohsiung City

1120

GSK Investigational Site, Adana

1425

GSK Investigational Site, Buenos Aires

1602

GSK Investigational Site, Florida

3500

GSK Investigational Site, Hasselt

4004

GSK Investigational Site, Plovdiv

5000

GSK Investigational Site, Córdoba

5530

GSK Investigational Site, Mont Gaston

6300

GSK Investigational Site, Haskovo

14004

GSK Investigational Site, Córdoba

15006

GSK Investigational Site, A Coruña

20251

GSK Investigational Site, Hamburg

20520

GSK Investigational Site, Turku

21565

GSK Investigational Site, Incheon

23007

GSK Investigational Site, Jaén

23040

GSK Investigational Site, La Paz BCS

23561

GSK Investigational Site, Taipei

28007

GSK Investigational Site, Madrid

28010

GSK Investigational Site, Madrid

28013

GSK Investigational Site, Aravaca

28033

GSK Investigational Site, Madrid

28222

GSK Investigational Site, Madrid

29016

GSK Investigational Site, Málaga

30202

GSK Investigational Site, Cartagena Murcia

31008

GSK Investigational Site, Pamplona

33006

GSK Investigational Site, Oviedo

33064

GSK Investigational Site, Pessac

34474

GSK Investigational Site, Ocala

34722

GSK Investigational Site, Istanbul

35016

GSK Investigational Site, Las Palmas de Gran Canar

35033

GSK Investigational Site, Rennes

37007

GSK Investigational Site, Salamanca

37203

GSK Investigational Site, Nashville

39008

GSK Investigational Site, Santander

40503

GSK Investigational Site, Lexington

40509

GSK Investigational Site, Lexington

41014

GSK Investigational Site, Seville

41404

GSK Investigational Site, Daegu

44280

GSK Investigational Site, Guadajalara

47003

GSK Investigational Site, Valladolid

48106

GSK Investigational Site, Ann Arbor

48903

GSK Investigational Site, BaracaldoVizcaya

49000

GSK Investigational Site, Angers

56100

GSK Investigational Site, Lorient

68114

GSK Investigational Site, Omaha

70210

GSK Investigational Site, Kuopio

76104

GSK Investigational Site, Fort Worth

78209

GSK Investigational Site, San Luis Potosí City

87042

GSK Investigational Site, Limoges

92100

GSK Investigational Site, Boulogne-Billancourt

96819

GSK Investigational Site, Honolulu

98506

GSK Investigational Site, Olympia

110075

GSK Investigational Site, New Delhi

122001

GSK Investigational Site, Gūrgaon

200030

GSK Investigational Site, Shanghai

210006

GSK Investigational Site, Nanjing

230001

GSK Investigational Site, Hefei

310006

GSK Investigational Site, Hangzhou

416234

GSK Investigational Site, Gokul Shirgoan

422005

GSK Investigational Site, Apex Wellness Hospital

560066

GSK Investigational Site, Bangalore

560085

GSK Investigational Site, Bangalore

590010

GSK Investigational Site, Belagavi

610000

GSK Investigational Site, Chengdu

700020

GSK Investigational Site, Kolkata

751007

GSK Investigational Site, Bhubaneshwar

751019

GSK Investigational Site, Bhubaneswar

R8324CVE

GSK Investigational Site, Cipoletti Rio Negro

C1426AGE

GSK Investigational Site, Ciudad Autonoma de Buenos Aire

C1056ABI

GSK Investigational Site, Ciudad Autonoma de Bueno

M5500AYB

GSK Investigational Site, Mendoza

S2002KDT

GSK Investigational Site, Rosario

S2002

GSK Investigational Site, Rosario

T4000

GSK Investigational Site, San Miguel de Tucumán

14784-400

GSK Investigational Site, Barretos

66.073-005

GSK Investigational Site, Belém

80810-050

GSK Investigational Site, CuritibaPR

88034-000

GSK Investigational Site, Florianópolis

60336-232

GSK Investigational Site, Fortaleza

86015-520

GSK Investigational Site, Londrina

76.834-899

GSK Investigational Site, Porto VelhoRondOnia

40414-120

GSK Investigational Site, Salvador

15090-000

GSK Investigational Site, SAo JosE Do Rio PretoSP

04312903

GSK Investigational Site, São Paulo

29043-260

GSK Investigational Site, Vitória

B3H 1V7

GSK Investigational Site, Halifax

Unknown

GSK Investigational Site, Hangzhou

GSK Investigational Site, Shatin

GSK Investigational Site, Panama City

GSK Investigational Site, Punta Pacifica Panama City Panama

380 016

GSK Investigational Site, Ahmedabad-380016

466-8560

GSK Investigational Site, Aichi

273-8588

GSK Investigational Site, Chiba

790-0024

GSK Investigational Site, Ehime

791-0280

GSK Investigational Site, Ehime

812-8582

GSK Investigational Site, Fukuoka

814-0180

GSK Investigational Site, Fukuoka

503-8502

GSK Investigational Site, Gifu

377-0280

GSK Investigational Site, Gunma

737-0023

GSK Investigational Site, Hiroshima

062-0931

GSK Investigational Site, Hokkaido

665-0827

GSK Investigational Site, Hyōgo

670-8520

GSK Investigational Site, Hyōgo

236-0051

GSK Investigational Site, Kanagawa

612-8555

GSK Investigational Site, Kyoto

515-8544

GSK Investigational Site, Mie

981-0914

GSK Investigational Site, Miyagi

981-1293

GSK Investigational Site, Miyagi

852-8501

GSK Investigational Site, Nagasaki

951-8566

GSK Investigational Site, Niigata

710-8602

GSK Investigational Site, Okayama

591-8555

GSK Investigational Site, Osaka

596-8501

GSK Investigational Site, Osaka

329-0498

GSK Investigational Site, Tochigi

104-0045

GSK Investigational Site, Tokyo

113-8603

GSK Investigational Site, Tokyo

162-8655

GSK Investigational Site, Tokyo

683-8504

GSK Investigational Site, Tottori

641-8510

GSK Investigational Site, Wakayama

06700

GSK Investigational Site, Mexico City

1815 JD

GSK Investigational Site, Alkmaar

7512 KZ

GSK Investigational Site, Enschede

02841

GSK Investigational Site, Seoul

03312

GSK Investigational Site, Seoul

05505

GSK Investigational Site, Seoul

08308

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

08003

GSK Investigational Site, Barcelona

08023

GSK Investigational Site, Barcelona

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

SE-801 87

GSK Investigational Site, Gävle

06560

GSK Investigational Site, Ankara

06800

GSK Investigational Site, Ankara

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

iTeos Therapeutics

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY